Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Genix Pharmaceuticals Corp V.GENX

Alternate Symbol(s):  GENPF

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.


TSXV:GENX - Post by User

Post by Sonbosson Jul 14, 2020 2:25pm
585 Views
Post# 31266680

Coule be a game changer Whitehorse hc approval!

Coule be a game changer Whitehorse hc approval!
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-enters-definitive-130000064.html

"We are truly excited about acquiring the global rights to Flu-X®. It was used safely and effectively in China during the SARS-CoV epidemic and has been shown to be effective against several coronaviruses1," stated Sina Pirooz, the Company's CEO. "Since there are striking similarities between the SARS and COVID-19 coronaviruses, we are encouraged about the potential of Flu-X® on COVID-19," added Mr. Pirooz

GENIX plans to commence global sales of Flu-X® immediately and in Canada once regulatory approval



Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-completes-purchase-090000198.html


Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
https://finance.yahoo.com/news/genix-acquires-exclusive-rights-sucanon-194200744.html
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities